Chinook TherapeuticsKDNY
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Chinook Therapeutics Inc. (KDNY) in their 13F filings. The largest holder was Parallel Advisors, LLC ($0).
- Company
- Chinook Therapeutics Inc.
- CUSIP
- 16961L106
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Parallel Advisors, LLC | 0.00% | No change | 5 | $0 |
"% of holder's portfolio" is KDNY's weight in each manager's 13F, not the share of Chinook Therapeutics Inc. the manager owns.